A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
RTW BIOTECH OPPORTUNITIES LTD O operates in the Asset Management industry, Financial Services sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - |
| Net Income | 34M | 34M | 83M | -39M | -64M |
| EPS | $0.00 | - | - | - | - |
| Free Cash Flow | 124M | 124M | 34M | 10M | -45M |
| ROIC | 6.2% | 4.7% | - | -8.7% | -13.6% |
| Gross Margin | - | - | - | - | - |
| Debt/Equity | 0.00 | - | - | - | - |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | 39M | 39M | 85M | -39M | -64M |
| Operating Margin | 0.0% | - | - | - | - |
| ROE | 5.4% | 5.4% | - | -10.7% | -16.6% |
| Shares Outstanding | 0M | - | - | - | - |
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | N/A | N/A | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| R&D | -238K | -743K | -475K | -849K | -849K |
| SG&A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -64M | -39M | 85M | 39M | 39M |
| Op. Margin | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -64M | -39M | 83M | 34M | 34M |
| Net Margin | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | -13.6% | -8.7% | N/A | 4.7% | 6.2% |
| ROE | -16.6% | -10.7% | N/A | 5.4% | 5.4% |
| ROA | -14.6% | -9.4% | 19.6% | 5.7% | 4.5% |
| Cash Flow | |||||
| Op. Cash Flow | -45M | 10M | 34M | 124M | 124M |
| Free Cash Flow | -45M | 10M | 34M | 124M | 124M |
| Owner Earnings | -45M | 10M | 34M | 124M | 124M |
| CapEx | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | N/A | 0 |
| D&A | 0 | 0 | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 2.1M | 11M | 11M |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||
| Net Debt | N/A | N/A | N/A | N/A | -5.4M |
| Cash & Equiv. | 6.5M | 7.0M | 2.7M | 5.4M | 5.4M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | N/A | N/A | N/A | N/A | 0.00 |
| Interest Coverage | -297.4 | -49.6 | 54.3 | 8.2 | 8.2 |
| Equity | 387M | 348M | N/A | 633M | 633M |
| Total Assets | 439M | 402M | 446M | 760M | 760M |
| Total Liabilities | 52M | 54M | N/A | 127M | 127M |
| Intangibles | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A |
| Working Capital | N/A | N/A | N/A | N/A | N/A |
| Current Assets | N/A | N/A | N/A | N/A | N/A |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A |
| Per Share Data | |||||
| EPS | N/A | N/A | N/A | N/A | 0.00 |
| Owner EPS | N/A | N/A | N/A | N/A | N/A |
| Book Value | N/A | N/A | N/A | N/A | 0.00 |
| Cash Flow/Share | N/A | N/A | N/A | N/A | 0.00 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | N/A | N/A | N/A | N/A | 0.0M |
| Valuation | |||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A |
| P/FCF | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | -0.1 |
| Price/Book | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 0 | 0 | 0 | 0 | 0 |
| Avg. Price | 2.02 | 1.26 | 1.23 | 1.46 | 2.14 |
| Year-End Price | 1.58 | 1.15 | 1.40 | 1.43 | 2.14 |
RTW BIOTECH OPPORTUNITIES LTD O passes 0 of 9 quality checks, indicating weak fundamentals.
RTW BIOTECH OPPORTUNITIES LTD O (RTW-L) has a 5-year average return on invested capital (ROIC) of -5.9%. This is below average and may indicate limited pricing power.
RTW BIOTECH OPPORTUNITIES LTD O (RTW-L) does not currently pay a regular dividend.
RTW BIOTECH OPPORTUNITIES LTD O (RTW-L) operates in the Asset Management industry, within the Financial Services sector.
RTW BIOTECH OPPORTUNITIES LTD O (RTW-L) generated $124 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
RTW BIOTECH OPPORTUNITIES LTD O (RTW-L) has a return on equity (ROE) of 5.4%. This indicates moderate shareholder returns.
The Ledger Terminal provides 4 years of financial data for RTW BIOTECH OPPORTUNITIES LTD O (RTW-L), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
No recent press releases.